Irisin ameliorates UUO-induced renal interstitial fibrosis through TGF-β1/periostin/MMP-2 signaling pathway
PLOS ONE · 13.06.2024 · 19 (6) · e0299389
DOI: 10.1371/journal.pone.0299389 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 13.06.2024. Verfasst von Yashu Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Ureteral Obstruction, Fibrosis, Fibronectins, Matrix Metalloproteinase 2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the Hebei Science and Technology Department Program.
Abstract (Originalsprache)
Renal fibrosis is the most common pathway in progressive kidney diseases. The unilateral ureteral obstruction (UUO) model is used to induce progressive renal fibrosis. We evaluated the effects of irisin on renal interstitial fibrosis in UUO mice. The GSE121190, GSE36496, GSE42303, and GSE96101 datasets were downloaded from the Gene Expression Omnibus (GEO) database. In total, 656 differentially expressed genes (DEGs) were identified in normal and UUO mouse renal samples. Periostin and matrix metalloproteinase-2 (MMP-2) were selected to evaluate the effect of irisin on renal fibrosis in UUO mice. In UUO mice, irisin ameliorated renal function, decreased the expression of periostin and MMP-2, and attenuated epithelial-mesenchymal transition and extracellular matrix deposition in renal tissues. In HK-2 cells, irisin treatment markedly attenuated TGF-β1-induced expression of periostin and MMP-2. Irisin treatment also inhibited TGF-β1-induced epithelial-mesenchymal transition, extracellular matrix formation, and inflammatory responses. These protective effects of irisin were abolished by the overexpression of periostin and MMP-2. In summary, irisin treatment can improve UUO-induced renal interstitial fibrosis through the TGF-β1/periostin/MMP-2 signaling pathway, suggesting that irisin may be used for the treatment of renal interstitial fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Hebei Medical University, Shijiazhuang, China.
- Department of Oncology, Hebei General Hospital, Shijiazhuang, China.
ORCID-Profile: Haijiang Wu
Förderung
- This work was supported by the Hebei Science and Technology Department Program
Zitieren
APA
Wang, Y., Deng, X., Wei, J., Yang, Z., Du, Y., Song, S., Shi, Y., & Wu, H. (2024). Irisin ameliorates UUO-induced renal interstitial fibrosis through TGF-β1/periostin/MMP-2 signaling pathway. PLOS ONE, 19(6), e0299389. https://doi.org/10.1371/journal.pone.0299389
Vancouver
Wang Y, Deng X, Wei J, Yang Z, Du Y, Song S, et al. Irisin ameliorates UUO-induced renal interstitial fibrosis through TGF-β1/periostin/MMP-2 signaling pathway. PLOS ONE. 2024;19(6):e0299389. doi:10.1371/journal.pone.0299389
BibTeX
@article{Wang2024,
author = {Wang, Yashu and Deng, Xinna and Wei, Jinying and Yang, Zhaohua and Du, Yunxia and Song, Shan and Shi, Yonghong and Wu, Haijiang},
title = {Irisin ameliorates UUO-induced renal interstitial fibrosis through TGF-β1/periostin/MMP-2 signaling pathway},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {6},
pages = {e0299389},
doi = {10.1371/journal.pone.0299389}
}
EUVIMED